Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA506902
Max Phase: Preclinical
Molecular Formula: C31H26N6O10
Molecular Weight: 642.58
Molecule Type: Small molecule
Associated Items:
ID: ALA506902
Max Phase: Preclinical
Molecular Formula: C31H26N6O10
Molecular Weight: 642.58
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C1c2c(c3c4ccc(O)cc4n(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)c3c3[nH]c4cc(O)ccc4c23)C(=O)N1NCc1cnccn1
Standard InChI: InChI=1S/C31H26N6O10/c38-11-19-26(41)27(42)28(43)31(46-19)47-37-18-8-14(40)2-4-16(18)21-23-22(20-15-3-1-13(39)7-17(15)35-24(20)25(21)37)29(44)36(30(23)45)34-10-12-9-32-5-6-33-12/h1-9,19,26-28,31,34-35,38-43H,10-11H2/t19-,26-,27+,28-,31+/m1/s1
Standard InChI Key: ZKTWDOVLQKYFQC-ZYOMLLCTSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 642.58 | Molecular Weight (Monoisotopic): 642.1710 | AlogP: 0.16 | #Rotatable Bonds: 6 |
Polar Surface Area: 235.75 | Molecular Species: NEUTRAL | HBA: 14 | HBD: 8 |
#RO5 Violations: 3 | HBA (Lipinski): 16 | HBD (Lipinski): 8 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 8.75 | CX Basic pKa: 1.78 | CX LogP: -1.09 | CX LogD: -1.11 |
Aromatic Rings: 6 | Heavy Atoms: 47 | QED Weighted: 0.11 | Np Likeness Score: 0.54 |
1. Sunami S, Nishimura T, Nishimura I, Ito S, Arakawa H, Ohkubo M.. (2009) Synthesis and biological activities of topoisomerase I inhibitors, 6-arylmethylamino analogues of edotecarin., 52 (10): [PMID:19397324] [10.1021/jm801641t] |
Source(1):